Study: Pharmacy access to buprenorphine boosts likelihood of continued treatment

IMPROVED RESULTS: Genoa Healthcare General Manager Andrew Terranova says providing buprenorphine treatment for patients at pharmacies can improve substance use disorder outcomes. 
PBN PHOTO/MICHAEL SALERNO
IMPROVED RESULTS: Genoa Healthcare General Manager Andrew Terranova says providing buprenorphine treatment for patients at pharmacies can improve substance use disorder outcomes. 
PBN PHOTO/MICHAEL SALERNO

Andrew Terranova, a pharmacist and general manager at Genoa Healthcare in Providence, was optimistic when his pharmacy signed onto a study intended to create new pathways for opioid use disorder treatment. Instead of starting at a doctor’s office or clinic, the study, led by researchers at Brown University and the University of Rhode Island, allowed

Already a Subscriber? Log in

To Continue Reading This Article

Become a Providence Business News subscriber and get immediate access to all of our premier content and much more.

Learn More and Become a Subscriber

No posts to display